Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Moscatiello

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 14, 2006
Diabetes and liver disease: an ominous associationSimona Moscatiello, Rita Manini, Giulio Marchesini
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Obesity-associated liver diseaseGiulio Marchesini, Simona Moscatiello, Silvia Di Domizio, et al.
Expert Opinion on Pharmacotherapy|November 3, 2011
Managing the combination of nonalcoholic fatty liver disease and metabolic syndromeSimona Moscatiello, Raffaella Di Luzio, Anna Simona Sasdelli, et al.
Hepatology International|July 24, 2015
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASHLuca Montesi, Arianna Mazzotti, Simona Moscatiello, et al.
Expert Opinion on Emerging Drugs|March 1, 2011
Treatment of non-alcoholic fatty liver disease with focus on emerging drugsGiulio Marchesini, Simona Moscatiello, Federica Agostini, et al.
Internal and Emergency Medicine|May 10, 2013
Physical activity for the prevention and treatment of metabolic disordersLuca Montesi, Simona Moscatiello, Marcella Malavolti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 2, 2006
Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetesRita Manini, Gabriele Forlani, Simona Moscatiello, et al.
Obesity Surgery|October 21, 2009
Metabolic syndrome and insulin resistance in subjects with morbid obesityValentina Soverini, Simona Moscatiello, Nicola Villanova, et al.
Clinical Pharmacology : Advances and Applications|November 27, 2013
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetesFrancesco Di Pierro, Pietro Putignano, Nicola Villanova, et al.
Acta Diabetologica|March 3, 2011
A psychological support program for individuals with Type 1 diabetesGabriele Forlani, Chiara Nuccitelli, Chiara Caselli, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 14, 2006
Diabetes and liver disease: an ominous associationSimona Moscatiello, Rita Manini, Giulio Marchesini
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Obesity-associated liver diseaseGiulio Marchesini, Simona Moscatiello, Silvia Di Domizio, et al.
Expert Opinion on Pharmacotherapy|November 3, 2011
Managing the combination of nonalcoholic fatty liver disease and metabolic syndromeSimona Moscatiello, Raffaella Di Luzio, Anna Simona Sasdelli, et al.
Hepatology International|July 24, 2015
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASHLuca Montesi, Arianna Mazzotti, Simona Moscatiello, et al.
Expert Opinion on Emerging Drugs|March 1, 2011
Treatment of non-alcoholic fatty liver disease with focus on emerging drugsGiulio Marchesini, Simona Moscatiello, Federica Agostini, et al.
Internal and Emergency Medicine|May 10, 2013
Physical activity for the prevention and treatment of metabolic disordersLuca Montesi, Simona Moscatiello, Marcella Malavolti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|December 2, 2006
Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetesRita Manini, Gabriele Forlani, Simona Moscatiello, et al.
Obesity Surgery|October 21, 2009
Metabolic syndrome and insulin resistance in subjects with morbid obesityValentina Soverini, Simona Moscatiello, Nicola Villanova, et al.
Clinical Pharmacology : Advances and Applications|November 27, 2013
Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetesFrancesco Di Pierro, Pietro Putignano, Nicola Villanova, et al.
Acta Diabetologica|March 3, 2011
A psychological support program for individuals with Type 1 diabetesGabriele Forlani, Chiara Nuccitelli, Chiara Caselli, et al.
Pageof 3